Hungary - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Hungary Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale grew 10.1% year on year. At €123,176,988.66 in 2019, the country was number 7 comparing other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Hungary is overtaken by Spain, which was ranked number 6 at €176,754,726.66 and is followed by Croatia at €79,001,763.77. Denmark topped the ranking with €3,801,340,964.3 in 2019, a fall of 2.9% versus 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy witnessed the best average annual growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.

Loading...

Date Euros
2019 123,176,988.66
2018 114,585,958.00
2017 121,284,327.00
2016 100,792,676.00
2015 93,604,216.00
Download all data from 2001 to 2019

How does Hungary rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 16 Countries Euros Last YoY 5‑years CAGR
1 #1
Denmark
3,801,340,964.30 2019 -2.9 % +26.5 % View data
2 #2
Belgium
1,624,727,500.00 2018 +46.2 % NA View data
6 #6
Spain
176,754,726.66 2019 +0.2 % +7.5 % View data
7 #7
Hungary
123,176,988.66 2019 +7.5 % +10.1 % View data
8 #8
Croatia
79,001,763.77 2019 +0.8 % +7.0 % View data
Compare all 16 countries

Go Top